Novabone

Founded in 2002, NovaBone is an industry-leading biotechnology company specializing in the development of bioactive solutions for bone and soft tissue regeneration in orthopedic and dental applications. Built on a foundation of scientific innovation and clinical validation, NovaBone introduced the first synthetic bioactive bone graft and continues to advance regenerative medicine through a broad portfolio of FDA-authorized products trusted by surgeons worldwide. With more than two million implantations across diverse clinical settings, NovaBone’s breakthrough bioactive technology is backed by extensive research, regulatory compliance, and two decades of real-world success. As pioneers in synthetic graft technology, NovaBone remains committed to advancing science-driven innovations that improve patient care, simplify surgical workflows, and set new standards in regenerative medicine.